Bonesupport Holding AB (BONEX) - Total Liabilities
Based on the latest financial reports, Bonesupport Holding AB (BONEX) has total liabilities worth Skr169.24 Million SEK (≈ $18.21 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BONEX cash flow metrics to assess how effectively this company generates cash.
Bonesupport Holding AB - Total Liabilities Trend (2014–2024)
This chart illustrates how Bonesupport Holding AB's total liabilities have evolved over time, based on quarterly financial data. Check Bonesupport Holding AB liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Bonesupport Holding AB Competitors by Total Liabilities
The table below lists competitors of Bonesupport Holding AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Thanachart Capital Public Company Limited
BK:TCAP-R
|
Thailand | ฿76.27 Billion |
|
China National Accord Medicines Corp Ltd
SHE:000028
|
China | CN¥29.01 Billion |
|
Xinlei Compressor Co. Ltd. A
SHE:301317
|
China | CN¥1.03 Billion |
|
Greatech Technology Bhd
KLSE:0208
|
Malaysia | RM192.36 Million |
|
Minmetals Development Co Ltd
SHG:600058
|
China | CN¥16.54 Billion |
|
Shanghai SK Automation Technology Co. Ltd. A
SHG:688155
|
China | CN¥3.35 Billion |
|
Dongsuh
KO:026960
|
Korea | ₩63.60 Billion |
|
IBF Financial Holdings Co Ltd
TW:2889
|
Taiwan | NT$378.01 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down Bonesupport Holding AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bonesupport Holding AB (BONEX) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 2.34 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bonesupport Holding AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bonesupport Holding AB (2014–2024)
The table below shows the annual total liabilities of Bonesupport Holding AB from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr152.23 Million ≈ $16.38 Million |
+5.98% |
| 2023-12-31 | Skr143.64 Million ≈ $15.46 Million |
+39.60% |
| 2022-12-31 | Skr102.89 Million ≈ $11.07 Million |
+31.55% |
| 2021-12-31 | Skr78.22 Million ≈ $8.42 Million |
+17.94% |
| 2020-12-31 | Skr66.32 Million ≈ $7.14 Million |
-7.92% |
| 2019-12-31 | Skr72.02 Million ≈ $7.75 Million |
+51.28% |
| 2018-12-31 | Skr47.61 Million ≈ $5.12 Million |
-67.37% |
| 2017-12-31 | Skr145.90 Million ≈ $15.70 Million |
-5.57% |
| 2016-12-31 | Skr154.50 Million ≈ $16.63 Million |
+69.22% |
| 2015-12-31 | Skr91.31 Million ≈ $9.83 Million |
+2.43% |
| 2014-12-31 | Skr89.14 Million ≈ $9.59 Million |
-- |
About Bonesupport Holding AB
Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin duri… Read more